SIRT4, able to inhibit cancer stem cells proliferation and survival, is found downregulated in breast cancer, and its levels are inversely correlated to SIRT1 expression and linked to acquisition of breast cancer aggressive phenotype [62]. This evidence concerns the gene SIRT1 and breast carcinoma.